-
ANDERSON PARTNERS ADVERTISING C/O METHODIST PHYS - Ad from 2024-11-02
02 Nov 2024 06:56 GMT
-
Anderson Partners Advertising C/o Methodist Phys
16 Oct 2024 23:45 GMT
-
ANDERSON PARTNERS ADVERTISING C/O METHODIST PHYS - Ad from 2024-10-05
05 Oct 2024 08:34 GMT
Detect.
Test.
Treat.
Total lung care only at Methodist
IN-DEPTH LUNG-SCREENING
Early detection saves lives and our unique
program identifies potential respiratory
diseases and cancers sooner.
SPECIALIZED TECHNOLOGY
Fully robotic technologies access smaller …
-
MD Anderson partners with Rice on data initiative
12 Sep 2024 20:43 GMT
University of Texas MD Anderson Cancer Center and Rice University, both based in Houston, have partnered to launch a new operational research initiative aimed at improving cancer care operations with data.
The Center for Operations Research in Cancer will …
-
ANDERSON PARTNERS ADVERTISING C/O METHODIST PHYS - Ad from 2024-07-06
06 Jul 2024 07:53 GMT
-
ANDERSON PARTNERS ADVERTISING C/O METHODIST PHYS - Ad from 2024-06-01
01 Jun 2024 09:52 GMT
-
MD Anderson partners on mRNA cancer vaccines
17 Apr 2024 15:33 GMT
Houston-based University of Texas MD Anderson Cancer Center has partnered with CureVac, a global biopharmaceutical company, to develop novel mRNA-based cancer vaccines.
The partnership will develop differentiated cancer vaccine candidates for certain …
-
ANDERSON PARTNERS-METHODIST
02 Sep 2023 08:06 GMT
-
MD Anderson partners with newly financed biotech to target 'undruggable' cancers
26 Jul 2023 23:07 GMT
The University of Texas MD Anderson Cancer Center is continuing its cancer therapy development program through a new partnership with a newly financed biotechnology company.
MD Anderson has entered a strategic collaboration with Watertown, Massachusetts- …
-
MD Anderson partners with Federation Bio to develop microbiome therapy
02 Feb 2023 15:12 GMT
The University of Texas MD Anderson Cancer Center has announced a strategic collaboration with Federation Bio for the development of a new microbiome treatment for immunotherapy-resistant cancer patients.
The collaboration is aimed at designing and …